MATTHEW 25 FUND NVO Holdings History
MATTHEW 25 FUND's Novo Nordisk AS Holding Summary
As of 2025-03-31, MATTHEW 25 FUND held 41,500.00 shares of Novo Nordisk AS(NVO), totaling $2.88 Mil. This investment constitutes 1.06% of their stock portfolio, and MATTHEW 25 FUND now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.
The initial trade took place in 2025Q1. And since then MATTHEW 25 FUND has made 1 purchases of NVO, at an average price of $82.59, for a total of 41,500.00 shares. Based on historical transaction data and NVO's current price of $69.64, MATTHEW 25 FUND's estimated gain on his NVO holdings is $-537,425.00, reflecting a -15.68% gain to date.
MATTHEW 25 FUND NVO ($69.64) Holding Chart
MATTHEW 25 FUND NVO ($69.64) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
